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Syncope is a difficult entity to assess. There are various causes of syncope,
including carotid artery hypersensitivity and glossopharyngeal irritation. In the
setting of head and neck cancer (HNC), syncope usually arises from mechanical
compression of the carotid sinus and tumor-induced irritation of the glosso-
pharyngeal nerve.
1,2 Attempts to relieve syncope have included vasoconstrictive
drugs, cardiac pacemaker placement, radiotherapy, and chemoradiothrapy.
3
Pacemaker therapy might be effective if syncope is a cardioinhibitory reflex type
with bradycardia. However, pacing unfortunately may not alleviate syncope
which results from a pure vasodepressor syncope.
4 Study on the role of che-
motherapy in syncope of head and neck cancer has rarely been reported.
5 We
describe a patient who suffered from the recurrent syncope due to tumor
compression of the carotid sinus, and initially failed with pacemaker but
successfully treated with chemotherapy.  
A 59-year-old man presented with recurrent syncopal episodes lasting for about
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Recurrent syncope as a complication of recurrent neck malignancy is an uncommon but well documented
association. The syncope is presumed to occur when a tumor mass invades the baroreceptor within the carotid sinus
or when it disrupts the afferent nerve fibers of the glossopharyngeal nerve. A 59-year-old man presented with
recurrent syncope and headache. He had a wide local excision including tonsillectomy and modified left radical
neck dissection for tonsilar cancer 4 years ago. A computed tomography scan revealed ill-defined lesions in left
parapharyngeal, carotid space and right upper jugular region. After clinical evaluation, cardiac pacemaker was
placed, but he still suffered from the syncope. Then, he received the chemotherapy with docetaxel and cisplatin.
The last hypotension event occurred on day 10 of the chemotherapy. Six months after 3 cycles of chemotherapy, he
remained in complete remission and resolution of syncope. We report a case in which syncope was associated with
a recurrence of tonsilar cancer and successfully treated with chemotherapy. 
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INTRODUCTION
CASE REPORT30 seconds and headache. Syncope was heralded by a
sensation of lightheadedness. 
The patient was hospitalized for further assessment.
After second day of admission, he had recurrent syncopal
episodes associated with seizure and hypotension. The
blood pressure was 50/30 mmHg with 20 beat per minute.
There was no clear precipitant for the syncopal attacks and
atropine was given immediately. Consciousness and nor-
mal heart rate were retrieved. 
Initial assessment included a computed tomography
(CT) scan of the brain, electroencephalography (EEG) and
neurologic exam which were unremarkable. However, 24-
h Holter monitoring showed long sinus pauses up to 3
seconds, correlating with syncope (Fig. 1). The syncope
was presumed due to sick sinus syndrome. A dual chamber
permanent pacemaker was placed and functioned nor-
mally. He was discharged, but was readmitted 1 week later
with persisting syncope and left ear pain which occurred
several times a week and occasionally associated with
generalized rigidity. When syncope was developed, the
pulse rate was normal but systolic blood pressure of 80
mmHg was observed. The patient recovered syncope
spontaneously. 
Consultation with the ear-nose-and-throat services was
requested for ear pain, and the hypopharyngeal mass was
found incidentally. Subsequently, CT scan of the neck was
performed and showed ill-defined lesions in the left
parapharyngeal, carotid spaces and right upper jugular
region (Fig. 2). A biopsy of the hypopharyngeal mass reve-
aled moderately differentiated squamous cell carcinoma.
His past medical history included tonsilar cancer which
had been diagnosed 4 years ago. The patient underwent
wide excision of left tonsilar area and modified radical
neck dissection (MRND). Subsequently he received adju-
vant radiotherapy of 5,040 cGy dose. The syncope was
thought to be associated with the cancer invasion in the
carotid sinus. Because the patient had already received
radiotherapy and operation, chemotherapy was considered
for the treatment. Therefore, Docetaxel (25 mg/m
2 on day
1, 8 and 15 in every 4 weeks) and Cisplatin 35 mg/m
2 (on
day 1, 8 and 15 in every 4 weeks) were administered. The
last hypotensive event occurred on day 10 of chemotherapy
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Fig. 1.A 24 hr Holter monitoring showed long sinus pauses for up to 3 seconds.
Fig. 2. A computed tomography scan revealed ovoid mass lesion compressing
the left internal carotid artery.
Fig. 3. A computed tomography scan performed after 3 cycles of chemotherapy
showed a considerable reduction of the mass which compresses the left
internal carotid artery. Chemotherapy for Recurrent Syncope by Head and Neck Cancer
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and never recurred again. CT scan performed after 3 cycles
of chemotherapy showed a complete resolution of tumor
(Fig. 3). Six cycles of chemotherapy were initially planned
for a period of 6 months. However, the patient experienced
recurrent pneumonia and severe vomiting even after dose
reduction and could not continue the chemotherapy. Six
months after 3 cycles of chemotherapy, he remained in
complete remission and resolution of syncope.
Syncope from HNC is uncommon, and there are several
previous reports to describe it.
6,7 Most reported cases of
syncope are caused by carcinoma, but neurofibroma and
lymphoma have also been reported.
8,9 The exact mech-
anism of syncope from HNC is not well characterized, but
it is similar to that of the carotid sinus syndrome (CSS).
10
An abnormally strong carotid sinus reflex is believed to
cause syncope from HNC. Weiss and Baker in their classic
description of CSS classified the cardiovascular responses
which leads to syncope to three forms: the cardioinhibitory
type (asystole or marked bradycardia, with or without
hypotension), the vasodepressor type (profound hypo-
tension without bradycardia) and the rare cerebral type
(without bradycardia or systemic hypotension).
11,12 In cardio-
inhibitory syncope the efferent arc is mainly vagal, affec-
ting the heart predominantly. In vasodepressor syncope,
the efferent arc is thought to be mainly sympathetic, affect-
ing mostly the peripheral vasculature. Pure vasodepressor
syncope is thought to account for only 5-10% of cases of
carotid sinus syncope, and the remainder is cardioinhi-
bitory type.
13 The significant bradycardia was obtained in
24 hours ECG (Holter) recording when our patient had
syncope, thus indicating that our case was the cardioinhi-
bitory type. 
Syncope from HNC is different from CSS in several
aspects. In the case of underlying neck malignancy, the
attacks are usually spontaneous and carotid sinus massage
does not characteristically provoke syncopal attacks.
14 The
syncope in HNC does occur not only when a tumor infilt-
rates the afferent nerve fibers of the glossopharyngeal
nerve, but also the baroreceptor within the carotid sinus.
Acute unilateral head or neck pain usually precedes the
syncopal episode from which patients may be aware of an
oncoming attack.
15 Brief seizures have also been reported
to accompany syncope both from hypersensitive carotid
sinus and glossopharyngeal neuralgia.
16 Seizures occur
mainly during prolonged periods of asystole or with pro-
found hypotension. In our case study, there was no pain in
the pharyngeal region prior to syncopal attack, but he had
brief seizure. 
There is no known single effective treatment for patients.
A variety of treatment might be considered to relieve syn-
cope. Such attempts include vasoconstrictive drugs, cardiac
pacemaker, radiotherapy and surgical resection of the
glossopharyngeal nerve.
4 Pacemaker therapy might relief
syncope resulting from a cardioinhibitory reflex with bra-
dycardia. However, pacing would not lessen syncope if
pure vasodepressor syncope develops.
3 In our case, the
pacemaker had initially been placed, but the patient did not
respond. Radiotherapy is effective in CSS in HNC. Radio-
therapy of the carotid sinus might control syncope in up to
2/3 of patients with carotid sinus hypersensitivity.
1 How-
ever, radiation has a drawback of delayed effect and concern
about the hazard of radiation. In our case, the patient could
not be treated with radiotherapy, because he was already
given considerable doses of radiation in the neck region.
Interruption of the glossopharyngeal nerve or carotid sinus
by surgery has been shown to be effective in preventing
syncope from carotid sinus hypersensitivity, even though it
is often palliative.
17 
Treatment of syncope of HNC with chemotherapy alone
has not been adequately documented.
5 Chemotherapy
showed moderate efficacy in HNC. The most active agents
include cisplatin, paclitaxel, docetaxel, 5-FU and cetu-
ximab. Especially, among newer agents, the taxanes seem
to be promising. Single-agent therapy with semisynthetic
taxane docetaxel demonstrated response rates from 27% to
42%.
18 Weekly docetaxel and cisplatin regimen appeared
to have a good activity and toxicity profile in HNC.
19 Ran-
domized trial has demonstrated significantly higher res-
ponse rates for the combination regimen than single agents.
20
In our case, chemotherapy was the only option for treatment.
Therefore, Docetaxel and Cisplatin were given weekly to
relieve symptoms. Our patient achieved complete remission
of tumor and resolution of syncope with four cycles of
chemotherapy. However, he could not receive more chemo-
therapy due to recurrent neutropenia and pneumonia. Ten
months after diagnosis and treatment, the patient had no
recurrence of syncope. Repeat CT scans and PET showed
complete resolution of the lesion.
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